Found 12 matching trials
Arimoclomol in Amyotropic Lateral Sclerosis
PHASE3A multicenter, randomized, double-blind, placebo-controlled, parallel group...
Location
St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center
Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial
PHASE3A multicenter, nonrandomized, open-label, uncontrolled clinical extension t...
Location
Phoenix Neurological Associates
A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
N/AThis is a prospective non-therapeutic observational study in NP-C patients....
Location
University Hospital Copenhagen (Rigshospitalet)
Study of Arimoclomol in Inclusion Body Myositis (IBM)
PHASE2Funding Source - FDA Office of Orphan Products Development (OOPD). The purp...
Location
Phoenix Neurological Associates
A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS
PHASE2The primary purpose of this study is to evaluate the safety and tolerabilit...
Location
University of California, Irvine Medical Center
Arimoclomol in Sporadic Inclusion Body Myositis
PHASE2Inclusion body myositis (IBM) is the most common progressive and debilitati...
Location
University of Kansas Medical Center
Early Access Program With Arimoclomol in US Patients With NPC
N/ANPC is a rare, relentlessly progressive, neurological disease and associate...
Location
University of Alabama Birmingham
Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C
PHASE2A prospective, randomized, double-blind, placebo controlled therapeutic stu...
Location
UCSF Benioff Children's Hospital Oakland
Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis
PHASE2The purpose of this study will be to demonstrate the safety, tolerability, ...
Location
University of Miami Miller School of Medicine
Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial
PHASE3A multicenter, non-randomized, open label trial, to assess long term safety...
Location
St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center